Ironwood Pharmaceuticals | IRWD - Fremdkapital





Fremdkapital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Almirall EUR 324.81M 61.32M 2025-12
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
Ardelyx USD 202.83M 696K 2025-12
Astellas Pharma JPY 320B 0 2026-03
AstraZeneca USD 25.96B 177M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Coherus Biosciences USD 51.08M 496K 2025-12
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Incyte USD 29.41M 785K 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
MacroGenics USD 70M 256K 2025-12
Moderna USD 603M 7M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
Pacira USD 367.66M 4.53M 2026-03
PTC Therapeutics USD 286.94M 1.74B 2026-03
Puma Biotechnology USD 10.87M 222K 2025-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Takeda JPY 4.37T 99.51B 2026-03
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12